EcoDrugPlus

Ensembl ID : ENSCHYG00000011799
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSCHYG00000009619
Gene Symbol: -
Cross references: -
260 Possible Orthologues:

Ensembl ID : ENSCHYG00000007291
Gene Symbol: -
Cross references: -
237 Possible Orthologues:

Ensembl ID : ENSCHYG00000005829
Gene Symbol: -
Cross references: -
379 Possible Orthologues:

Ensembl ID : ENSCHYG00000004942
Gene Symbol: -
Cross references: -
88 Possible Orthologues:

Ensembl ID : ENSCHYG00000004236
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSCHYG00000004079
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSCHYG00000003988
Gene Symbol: -
Cross references: -
379 Possible Orthologues:

Ensembl ID : ENSCHYG00000000426
Gene Symbol: -
Cross references: -
289 Possible Orthologues:

Ensembl ID : ENSCHYG00000000171
Gene Symbol: -
Cross references: -
460 Possible Orthologues:

Ensembl ID : ENSCHYG00000026511
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSCHYG00000025521
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).